Search results for "Venous thromboembolism"

Results 1 - 10 of about 243 for "Venous thromboembolism".

Intervention improved venous thromboembolism prophylaxis

A multi-faceted intervention increased venous thromboembolism (VTE) prophylaxis among medical and surgical patients in an Australian hospital, a new study reported.
March 2012

Venous thromboembolism in the elderly

Venous thromboembolism (VTE) is manifested clinically by deep venous thrombosis (DVT) and pulmonary embolism (PE). ... Venous thromboembolism. In: Petty TL, Seebass JS, eds. Pulmonary Disorders of the Elderly.
April 2007

New guidelines cover VTE prophylaxis, diagnosis, anticoagulation, and HIT

Several guidelines related to venous thromboembolism (VTE) prevention and treatment were recently published by the American Society of Hematology, with more promised soon. ... New guidelines on preventing, diagnosing, and treating venous thromboembolism
December 2018

Bonus online case: Antiphospholipid syndrome and bilateral adrenal hemorrhage

The patient was diagnosed with adrenal insufficiency due to suspected adrenal venous thrombosis and hemorrhage in the setting of the antiphospholipid antibody syndrome (APLS). ... Multiple studies have shown thrombi in the central veins of patients with
May 2019

Aspirin appears to reduce recurrence of VTE after stopping anticoagulants

Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study ... found. Aspirin reduced the risk of
June 2012

MKSAP quiz on venous thromboembolism

Family history is positive for venous thromboembolism in his father. He smokes 10 cigarettes daily. ... Which of the following is the most appropriate prophylaxis for the prevention of venous thromboembolism?
December 2014

Rivaroxaban at discharge did not significantly reduce deaths due to VTE, study finds

Patients who were randomized to 45 days of rivaroxaban instead of placebo did have lower risk of nonfatal venous thromboembolism (VTE), the industry-funded trial found. ... A discharge prescription of rivaroxaban for thromboprophylaxis did not reduce
August 2018

Tool for PE, heart failure drugs

Adverse outcomes, including return visits for PE-related symptoms within five days and recurrent venous thromboembolism, major hemorrhage, and all-cause mortality within 30 days, were also evaluated.
May 2019

Heart failure may be independent risk factor for VTE

Patients with heart failure in the hospital may be at higher risk for venous thromboembolism (VTE), according to a recent study. ... Making physicians more aware of the association between heart failure and venous thromboembolism could help to reduce the
December 2015

VTE update covers new drugs, recommendations

C urrently, it is the patient who feels pain if prophylaxis against venous thromboembolism (VTE) is not successfully implemented.
July 2010

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next